REDWOOD CITY, Calif., March 31 /PRNewswire/ -- iScience Surgical Inc., a developer of novel surgical devices for the treatment of ocular diseases, today announced it has closed $15 million in Series C financing. New investor Three Arch Partners led the round, with existing investors Prism Venture Partners, De Novo Ventures, Asset Management Partners and Pacific Horizon Ventures also contributing.
As part of the financing, Wilfred Jaeger, Co-Founder and Partner of Three Arch Partners, will also join the Company’s board of directors.
“As a highly accomplished healthcare investor and private practitioner MD, Wilfred understands the relevant issues in the development and execution of a successful healthcare start-up,” said Michael Nash, CEO, iScience Surgical. “His background complements the deep-seated operational expertise of our board members, providing iScience Surgical with the resources and guidance to successfully execute our commercialization plans.”
iScience Surgical is focused on developing high-resolution imaging systems and microsurgical instruments for the treatment of glaucoma. Glaucoma is a sight-threatening circulatory disorder of the eye that affects approximately 4.2 million Americans and 69 million people worldwide.
“Three Arch Partners is committed to identifying medical device companies that have the potential to fill a real void in treatment and significantly improve patient outcomes,” said Wilfred Jaeger, Co-Founder and Partner, Three Arch Partners. “iScience is clearly on track to develop innovative solutions for several major sight-threatening eye diseases. We look forward to our involvement in this exciting opportunity and working with the management team to realize the full potential of this breakthrough technology.”
About iScience Surgical
iScience Surgical, Inc. is a privately held company founded in 1999. It is developing high-resolution imaging systems and microsurgical instruments for the treatment of a wide range of ocular diseases. The Company’s products serve as a platform for a new generation of minimally invasive ophthalmic surgical procedures.
About Three Arch Partners
Three Arch Partners was formed in 1993 to provide young companies with access to relevant clinical and business resources, as well as capital. The firm was established and is positioned to integrate the traditional roles of venture capitalist and entrepreneur. Three Arch Partners invests exclusively in healthcare, considering opportunities in biotechnology, healthcare services, medical devices, and diagnostics.
For additional information on iScience’s investors, please visit: Three Arch Partners at http://www.threearchpartners.com/ Prism Venture Partners at http://www.prismventure.com/ De Novo Ventures at http://www.denovovc.com/ Asset Management Partners at http://www.assetman.com/ Pacific Horizon Ventures at http://www.pacifichorizon.com/
iScience Surgical Inc.
CONTACT: Lisa M. Black of LMBPR, +1-781-631-6377, lblack@lmbpr.com